P53 expression in small cell carcinoma of the urinary bladder: Biological and prognostic implications

Anticancer Research

Volumn 25, Issue 3 B, 2005, Pages 2001-2004

  Wang, Xiaoyan ^a   Jones, Timothy D ^a   Maclennan, Gregory T ^b   Yang, Ximing J ^c   Lopez Beltran, Antonio ^d   Eble, John N ^a   Koch, Michael O ^a   Lin, Haiqun ^e   Baldridge, Lee Ann ^a   Tretiakova, Maria ^f   Cheng, Liang ^a,g  

^a INDIANA UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d UNIVERSITY OF CÓRDOBA   (Spain)

^e YALE UNIVERSITY   (United States)

^f UNIVERSITY OF CHICAGO   (United States)

^g INDIANA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

p53; Prognosis; Small cell carcinoma; Survival; Urinary bladder

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; GENDER; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; SMALL CELL CARCINOMA; SMOKING HABIT; SURVIVAL RATE; TUMOR CELL;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SMALL CELL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; URINARY BLADDER NEOPLASMS;

EID: 21344453516     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Blomjous CE, Vos W, De Voogt HJ, Van der Valk P and Meijer CJ: Small cell carcinoma of the urinary bladder. A clinicopathologic, morphometric, immunohistochemical, and ultrastructural study of 18 cases. Cancer 64: 1347-1357, 1989.
2. Cheng L, Pan CX, Yang XJ, Lopez-Beltran A, MacLennan GT, Lin H, Kuzel TM, Papavero V, Tretiakova M, Nigro K et al: Small cell carcinoma of the urinary bladder: a clinicopathologic analysis of 64 patients. Cancer 101: 957-962, 2004.
3. Grignon DJ, Ro JY, Ayala AG, Shum DT, Ordonez NG, Logothetis CJ, Johnson DE and Mackay B: Small cell carcinoma of the urinary bladder. A clinicopathologic analysis of 22 cases. Cancer 69: 527-536, 1992.
4. Harris CC: Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies. J Natl Cancer Inst 88: 1442-1455, 1996.
5. Hollstein M, Sidransky D, Vogelstein B and Harris CC: p53 mutations in human cancers. Science 255: 49-53, 1991.
6. Hollstein M, Rice K, Greenblatt MS, Soussi T, Fuchs R, Sorlie T, Hovig E, Smith-Sorensen B, Montesano R and Harris CC. Database of p53 gene somatic mutations in human tumors and cell lines. Nucleic Acids Res 22: 3551-3555, 1994.
7. Quinlan DC, Davidson AG, Summers CL, Warden HE and Doshi HM: Accumulation of p53 protein correlates with a poor prognosis in human lung cancer. Cancer Res 52: 4828-4831, 1992.
8. Thor AD, Moore DH, II, Edgerton SM, Kawasaki ES, Reihsaus E, Lynch HT, Marcus JN, Schwartz L, Chen LC, Mayall BH et al: Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers. J Natl Cancer Inst 84: 845-855, 1992.
9. Martin HM, Filipe MI, Morris RW, Lane DP and Silvestre F: p53 expression and prognosis in gastric carcinoma. Int J Cancer 50: 859-862, 1992.
10. Aprikian AG, Sarkis AS, Fair WR, Zhang ZF, Fuks Z and Cordon-Cardo C: Immunohistochemical determination of p53 protein nuclear accumulation in prostatic adenocarcinoma. J Urol 757: 1276-1280, 1994.
11. Cheng L, Leibovich BC, Bergstralh EJ, Scherer BG, Pacelli A, Ramnani DM, Zincke H and Bostwick DG: p53 alteration in regional lymph node metastases from prostate carcinoma: a marker for progression? Cancer 85: 2455-2459, 1999.
12. Cheng L, Sebo TJ, Cheville JC, Slezak J, Bergstralh EJ, Paceli A, Neumann RM, Zincke H and Bostwick DG: P53 protein overexpression is associated with increased cell proliferation in patients with locally recurrent prostate carcinoma after radiation therapy. Cancer 85: 1293-1299, 1999.
13. Eble JN, Sauter G, Epstein JI and Sesterhenn IAE: World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. Lyon: IARC Press, 2004.
14. Greene FL, Page DL, Flemming ID, Fritz AG, Balch CM, Haller DG and Morrow M: AJCC Cancer Staging Manual, 6th edn. New York: Springer-Verlag, 2002.
15. Esrig D, Spruck CH, 3rd, Nichols PW, Chaiwun B, Steven K, Groshen S, Chen SC, Skinner DG, Jones PA and Cote RJ: p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer. Am J Pathol 143: 1389-1397, 1993.
16. Parwani AV, Geradts J, Caspers E, Offerhaus GJ, Yeo CJ, Cameron JL, Klimstra DS, Maitra A, Hruban RH and Argani P: Immunohistochemical and genetic analysis of non-small cell and small cell gallbladder carcinoma and their precursor lesions. Mod Pathol 16: 299-308, 2003.
17. Maitra A, Tascilar M, Hruban RH, Offerhaus GJ and Albores-Saavedra J: Small cell carcinoma of the gallbladder: a clinicopathologic, immunohistochemical, and molecular pathology study of 12 cases. Am J Surg Pathol 25: 595-601, 2001.
18. Atkin NB, Baker MC and Wilson GD: Chromosome abnormalities and p53 expression in a small cell carcinoma of the bladder. Cancer Genet Cytogenet 79: 111-114, 1995.
19. Soriano P, Navarro S, Gil M and Llombart-Bosch A: Small-cell carcinoma of the urinary bladder. A clinico-pathological study of ten cases. Virchows Arch 445: 292-297, 2004.
20. Wang HL and Lu DW: Detection of human papillomavirus DNA and expression of p16, Rb, and p53 proteins in small cell carcinomas of the uterine cervix. Am J Surg Pathol 28: 901-908, 2004.